Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment-Reference-Cited by-同舟云学术

Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment

Published:2016-11 Issue:11 Volume:11 Page:1869-1878
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Huynh Tiffany G.,Morales-Oyarvide Vicente,Campo Meghan J.,Gainor Justin F.,Bozkurtlar Emine,Uruga Hironori,Zhao Ling,Gomez-Caraballo Maria,Hata Aaron N.,Mark Eugene J.,Lanuti Michael,Engelman Jeffrey A.,Mino-Kenudson Mari

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference47 articles.

1. Clinical cancer advances 2013: annual report on progress against cancer from the American Society of Clinical Oncology;Patel;J Clin Oncol,2014

2. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014

3. Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers;Dogan;Clin Cancer Res,2012

4. A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations;Riely;J Thorac Oncol,2011

5. Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice;Yamaguchi;Lung Cancer,2013

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

2. Nomogram of myelosuppression and survival prognosis in patients with brain metastases from non-small cell lung adenocarcinoma by intrathecal injection of pemetrexed via the Ommaya Reservoir;2023-11-20

3. Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China;Annals of Surgical Oncology;2023-09-01

4. Efficacy of immunotherapy as second-line or later-line therapy and prognostic significance of KRAS or TP53 mutations in advanced non-small cell lung cancer patients;European Journal of Cancer Prevention;2023-04-05

5. Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers;JCO Precision Oncology;2023-03